Prelamin A-mediated nuclear envelope dynamics in normal and laminopathic cells

Research output: Contribution to journalArticlepeer-review


Prelamin A is the precursor protein of lamin A, a major constituent of the nuclear lamina in higher eukaryotes. Increasing attention to prelamin A processing and function has been given after the discovery, from 2002 to 2004, of diseases caused by prelamin A accumulation. These diseases, belonging to the group of laminopathies and mostly featuring LMNA mutations, are characterized, at the clinical level, by different degrees of accelerated aging, and adipose tissue, skin and bone abnormalities. The outcome of studies conducted in the last few years consists of three major findings. First, prelamin A is processed at different rates under physiological conditions depending on the differentiation state of the cell. This means that, for instance, in muscle cells, prelamin A itself plays a biological role, besides production of mature lamin A. Secondly, prelamin A post-translational modifications give rise to different processing intermediates, which elicit different effects in the nucleus, mostly by modification of the chromatin arrangement. Thirdly, there is a threshold of toxicity, especially of the farnesylated form of prelamin A, whose accumulation is obviously linked to cell and organism senescence. The present review is focused on prelamin A-mediated nuclear envelope modifications that are upstream of chromatin dynamics and gene expression mechanisms regulated by the lamin A precursor.

Original languageEnglish
Pages (from-to)1698-1704
Number of pages7
JournalBiochemical Society Transactions
Issue number6
Publication statusPublished - Dec 2011


  • Emerin
  • Emery-Dreifuss muscular dystrophy (EDMD)
  • Prelamin A
  • Progeroid laminopathy
  • SUN1
  • SUN2

ASJC Scopus subject areas

  • Biochemistry


Dive into the research topics of 'Prelamin A-mediated nuclear envelope dynamics in normal and laminopathic cells'. Together they form a unique fingerprint.

Cite this